The data forecasts a gradual increase in hospital discharges for deforming dorsopathies and spondylopathies in France from 2024 to 2028, with values escalating from 114.1 to 116.6 units per hundred thousand persons. Compared to the 2023 benchmark value of 113.5, the trend displays consistent annual growth of approximately 0.7% to 0.8% year-on-year. The forecasted CAGR for this period is about 0.8%, reflecting a steady upward trajectory.
Future trends to watch for include potential impacts of aging populations, advancements in medical treatments, and changes in healthcare policies, all of which may influence the rate of hospital discharges for these conditions.
Our readers also like:
Forecast: Hospital Average Length of Stay for Systemic Connective Tissue Disorders Cases in Italy
- Days
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Systemic Connective Tissue Disorders in France
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in Canada
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Soft Tissue Disorders Cases in Canada
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in Germany
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in Italy
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Intervertebral Disc Disorders Cases in Germany
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Systemic Connective Tissue Disorders in Germany
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Deforming Dorsopathies and Spondylopathies Cases in France
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Systemic Connective Tissue Disorders in the UK
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Deforming Dorsopathies and Spondylopathies Cases in Canada
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Intervertebral Disc Disorders Cases in Canada
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in Italy
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Soft Tissue Disorders Cases in the UK
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Soft Tissue Disorders Cases in the UK
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Soft Tissue Disorders Cases in Germany
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Global Hospital Discharges for Deforming Dorsopathies and Spondylopathies Cases by Country
- Units (Hospital Discharges)
- 2023
- ReportLinker Research
European Hospital Discharges for Deforming Dorsopathies and Spondylopathies Cases by Country
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2023
- ReportLinker Research
Forecast: Hospital Discharges for Intervertebral Disc Disorders Cases in Italy
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Average Length of Stay for Deforming Dorsopathies and Spondylopathies in France
- Days
- 2024 to 2028
- ReportLinker Research